{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:40:10Z","timestamp":1759452010815,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.vaccine.2021.02.030","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T04:04:22Z","timestamp":1619755462000},"page":"3216-3224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland"],"prefix":"10.1016","volume":"39","author":[{"given":"Aleksandra","family":"Polkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Rinta-Kokko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija","family":"Toropainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arto A.","family":"Palmu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Pekka","family":"Nuorti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.02.030_b0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.02.030_b0010","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2021.02.030_b0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/CMR.00070-09","article-title":"Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis","volume":"23","author":"Brouwer","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2021.02.030_b0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jinf.2010.04.008","article-title":"The risk of sequelae due to pneumococcal meningitis in high-income countries: A systematic review and meta-analysis","volume":"61","author":"Jit","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2021.02.030_b0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: A systematic review and meta-analysis","volume":"10","author":"Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.00008-11","article-title":"Pathogenesis and Pathophysiology of Pneumococcal Meningitis","volume":"24","author":"Mook-Kanamori","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2021.02.030_b0035","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(12)61187-8","article-title":"Effect of vaccines on bacterial meningitis worldwide","volume":"380","author":"McIntyre","year":"2012","journal-title":"Lancet"},{"issue":"360","key":"10.1016\/j.vaccine.2021.02.030_b0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis","volume":"15","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.02.030_b0045","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/0102-311X00169913","article-title":"Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil","volume":"31","author":"Grando","year":"2015","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.vaccine.2021.02.030_b0050","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1016\/j.vaccine.2017.06.070","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children","volume":"35","author":"Ruiz-Contreras","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.030_b0055","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/INF.0b013e31817bd2dc","article-title":"Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine","volume":"27","author":"Casado-Flores","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2021.02.030_b0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in the Netherlands, 2006\u201314: a prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0065","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0070","doi-asserted-by":"crossref","unstructured":"Alari A, Chaussade H, Domenech De Cell\u00e8s M, Le Fouler L, Varon E, Opatowski L, et al. Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis. BMC Med 2016;14:211. doi:10.1186\/s12916-016-0755-7.","DOI":"10.1186\/s12916-016-0755-7"},{"key":"10.1016\/j.vaccine.2021.02.030_b0075","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1016\/j.vaccine.2017.09.050","article-title":"Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States","volume":"35","author":"Jacobs","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.030_b0080","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid2407.170721","article-title":"Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009\u2013June 2015","volume":"24","author":"Regev-Yochay","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0090","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0095","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.vaccine.2018.04.010","article-title":"Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil","volume":"36","author":"Brandileone","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.030_b0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.02.030_b0105","doi-asserted-by":"crossref","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children \u2013 A Population-Based Study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2021.02.030_b0110","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.vaccine.2018.03.001","article-title":"Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland","volume":"36","author":"Rinta-Kokko","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.030_b0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2334-8-96","article-title":"Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies","volume":"8","author":"Klemets","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0120","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/JCM.00689-12","article-title":"From quellung to multiplex PCR, and back when needed, in pneumococcal serotyping","volume":"50","author":"Siira","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"419","key":"10.1016\/j.vaccine.2021.02.030_b0125","article-title":"Pneumococcal serotype evolution in Western Europe","volume":"15","author":"Tin Tin Htar","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0135","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12325-013-0051-2","article-title":"A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis","volume":"30","author":"Tin Tin Htar","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.vaccine.2021.02.030_b0140","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3201\/eid1605.091223","article-title":"Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands","volume":"16","author":"Rodenburg","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0145","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales","volume":"51","author":"Pichon","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2021.02.030_b0150","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3201\/eid2509.180747","article-title":"Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July1, 2000-June 30,2016","volume":"25","author":"Oligbu","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0155","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.vaccine.2016.07.038","article-title":"Impact of PCV7\/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD","volume":"34","author":"Ben-Shimol","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.030_b0160","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cid\/civ368","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children","volume":"61","author":"Olarte","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0165","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1099\/jmm.0.000346","article-title":"Genetic profiles and antimicrobial resistance of Streptococcus pneumoniae non-PCV10 serotype isolates recovered from meningitis cases in Salvador, Brazil","volume":"65","author":"Azevedo","year":"2016","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2021.02.030_b0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12879-015-0787-1","article-title":"Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany","volume":"15","author":"Im\u00f6hl","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/14760584.2018.1516551","article-title":"Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience","volume":"17","author":"Mrkvan","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.02.030_b0180","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/cid\/cix685","article-title":"Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations","volume":"65","author":"Naucler","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0185","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.vaccine.2016.02.043","article-title":"Vaccine effectiveness of PCV13 in a 3+1 vaccination schedule","volume":"34","author":"Weinberger","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.030_b0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0195","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1016\/j.vaccine.2018.07.069","article-title":"Commentary on paradoxical observations pertaining to the impact of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae infections in children","volume":"36","author":"De Wals","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.030_b0200","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.vaccine.2019.11.026","article-title":"Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia","volume":"38","author":"Forstner","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.030_b0205","doi-asserted-by":"crossref","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2021.02.030_b0210","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","article-title":"Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries\u202f: implications for adult vaccination","volume":"74","author":"Hanquet","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2021.02.030_b0215","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14760584.2017.1362339","article-title":"Streptococcus pneumoniae serotype 19A\u202f: worldwide epidemiology","volume":"16","author":"Isturiz","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.02.030_b0220","doi-asserted-by":"crossref","unstructured":"Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, et al. Population Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States , 2005. J Infect Dis. 2008;197:1016-1027. doi: 10.1086\/528996.","DOI":"10.1086\/528996"},{"key":"10.1016\/j.vaccine.2021.02.030_b0225","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1473-3099(14)70805-9","article-title":"Epidemiology of bacterial meningitis in the USA from 1997 to 2010: A population-based observational study","volume":"14","author":"Castelblanco","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.02.030_b0230","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jped.2014.07.002","article-title":"Pneumococcal meningitis : epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine","volume":"91","author":"Hirose","year":"2015","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.vaccine.2021.02.030_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039150","article-title":"Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2021.02.030_b0240","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1212\/WNL.0b013e3181f96297","article-title":"Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis","volume":"75","author":"Brouwer","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2021.02.030_b0245","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1016\/j.vaccine.2018.10.003","article-title":"The choice of analytical methodology can alter conclusions regarding herd effects of paediatric pneumococcal vaccination programmes","volume":"36","author":"Pir\u00e7on","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.030_b0250","doi-asserted-by":"crossref","first-page":"e015080","DOI":"10.1136\/bmjopen-2016-015080","article-title":"Bacterial meningitis in Finland, 1995\u20132014: a population-based observational study","volume":"7","author":"Polkowska","year":"2017","journal-title":"BMJ Open"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21001869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21001869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:57:00Z","timestamp":1759402620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21001869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":49,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0264410X21001869"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}